# Step 13 Feature Layer — Comprehensive Evaluation Report

## 🎯 Final Verdict: **PASS** (13/13 Criteria Satisfied)
- **Report JSON**: [`evaluations/step13_features_report.json`](file:///home/dicksone/Documents/MedGraphRag/evaluations/step13_features_report.json)
- **Execution Time**: `176.68 s`
- **Peak Hardware**: RAM `3.93 GB` | VRAM `4776.0 MB`

---

## 📋 1. Evaluation Criteria Matrix

| # | Criterion | Evaluated Condition | Status |
| :--- | :--- | :--- | :---: |
| **1** | **Trend Direction Correct** | Validated during probe execution | ✅ PASS |
| **2** | **Unit Alignment Correct** | Validated during probe execution | ✅ PASS |
| **3** | **Caregap Reconciliation Correct** | Validated during probe execution | ✅ PASS |
| **4** | **Caregap Guideline Citations 100Pct** | Validated during probe execution | ✅ PASS |
| **5** | **Coverage Classes Match Expectations** | Validated during probe execution | ✅ PASS |
| **6** | **Disclaimer Present 100Pct** | Validated during probe execution | ✅ PASS |
| **7** | **No Diagnosis Framing** | Validated during probe execution | ✅ PASS |
| **8** | **Private Store Isolation** | Validated during probe execution | ✅ PASS |
| **9** | **Global Index Untouched** | Validated during probe execution | ✅ PASS |
| **10** | **Vram Under 5500Mb** | Validated during probe execution | ✅ PASS |
| **11** | **Ram Under 12Gb** | Validated during probe execution | ✅ PASS |
| **12** | **Per Feature Latency Under 15S** | Validated during probe execution | ✅ PASS |
| **13** | **Regression Step11 Api Pass 7 Of 7** | Validated during probe execution | ✅ PASS |

---

## 📈 2. Feature 1 — MedTrend (Longitudinal Trajectory Results)

| Lab Test | Earliest Val | Latest Val | Delta (Δ) | Rate/Month | Direction | Significant? | Clinical Reason |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: | :--- |
| **Creatinine** | 97.24 umol/L | 167.96 umol/L | `+70.72` | `+22.8994/mo` | `worsening` | ⚠️ YES | Crossed upper reference threshold (115.0 umol/L). |
| **Hemoglobin A1c** | 6.9 % | 7.8 % | `+0.9` | `+0.2914/mo` | `worsening` | ⚠️ YES | Exacerbation: Rose further above upper threshold (5.6 %) by +0.90 %. |
| **Potassium** | 4.2 mmol/L | 4.3 mmol/L | `+0.1` | `+0.0324/mo` | `stable` | No | Normal variance |
| **Sodium** | 140.0 mmol/L | 139.0 mmol/L | `-1` | `-0.3238/mo` | `stable` | No | Normal variance |
| **Glucose** | 6.105 mmol/L | 8.0475 mmol/L | `+1.9425` | `+0.629/mo` | `worsening` | ⚠️ YES | Exacerbation: Rose further above upper threshold (5.6 mmol/L) by +1.94 mmol/L. |

**Graph-Derived Possible Causes for Significant Trajectory:**
- `LabTest(Creatinine) -[LABTEST_RELATED_TO]-> Disease(Chronic Kidney Disease)`
- `LabTest(Creatinine) -[LABTEST_RELATED_TO]-> Disease(Acute Kidney Injury)`

---

## 🩺 3. Feature 2 — CareGap (Guideline Reconciliation Results)

| Gap Type | Condition | Recommended Check | Observed Value | Guideline Target | Provenance |
| :--- | :--- | :--- | :---: | :--- | :--- |
| **⚠️ Out of Target** | Type 2 Diabetes Mellitus | Hemoglobin A1c | `8.2 %` | HbA1c < 7.0% for most nonpregnant adults | `Research_papers/PMC/XML/PMC9107726/article` |
| **🔍 Missing Check** | Type 2 Diabetes Mellitus | Creatinine | `*(Not Tested)*` | Annual evaluation of estimated GFR / serum creatinine | `Clinical_practice_guidlines/Nice_guidlines/chronic-kidney-disease-assessment-and-management-pdf-66143713055173` |
| **🔍 Missing Check** | Type 2 Diabetes Mellitus | Urine Albumin | `*(Not Tested)*` | Annual urine albumin-to-creatinine ratio (uACR < 30 mg/g) | `Clinical_practice_guidlines/Nice_guidlines/chronic-kidney-disease-assessment-and-management-pdf-66143713055173` |
| **🔍 Missing Check** | Hypertension | Creatinine | `*(Not Tested)*` | Baseline & annual renal function assessment | `Clinical_practice_guidlines/Nice_guidlines/hypertension-in-adults-diagnosis-and-management-pdf-66141722710213` |

---

## 🗺️ 4. Feature 3 — Evidence Coverage Map Results

### Query 1: *"warfarin INR monitoring guidelines atrial fibrillation"* (Overall Coverage: **STRONG**)
| Sub-Question | Coverage | Top Fused Score | Distinct Docs | Suggested Rephrase |
| :--- | :---: | :---: | :---: | :--- |
| What is the clinical definition and diagnostic criteria for warfarin INR monitoring guidelines atrial fibrillation? | `strong` | `0.1766` | 10 | *(Adequate coverage)* |
| What are the evidence-based management and monitoring recommendations for warfarin INR monitoring guidelines atrial fibrillation? | `strong` | `0.1774` | 10 | *(Adequate coverage)* |

### Query 2: *"potassium hyperkalemia ECG changes peaked T waves treatment"* (Overall Coverage: **STRONG**)
| Sub-Question | Coverage | Top Fused Score | Distinct Docs | Suggested Rephrase |
| :--- | :---: | :---: | :---: | :--- |
| What are the ECG changes associated with potassium hyperkalemia? | `strong` | `0.1777` | 10 | *(Adequate coverage)* |
| What are peaked T waves in the context of hyperkalemia? | `strong` | `0.1783` | 10 | *(Adequate coverage)* |
| What is the treatment for potassium hyperkalemia? | `strong` | `0.1777` | 10 | *(Adequate coverage)* |

---

## 🔒 5. Regression & Global Index Integrity

| Metric | Expected Baseline | Observed Value | Status |
| :--- | :---: | :---: | :---: |
| **Step 11 API Probe** | `7/7 PASS` | `7/7 (PASS)` | ✅ **PASS** |
| **FAISS Index Vectors** | `2,294,038` | `2,294,038` | ✅ **100% Intact** |
| **Kùzu Graph Nodes** | `2,499,528` | `2,499,528` | ✅ **100% Intact** |
| **Private Store Isolation** | `Zero Cross-User Leak` | `Verified` | ✅ **PASS** |
